Prevention Of Rsv clinical trials

Explore recruiting prevention of rsv clinical trials.

Recruiting prevention of rsv studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Prevention Of Rsv trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants

Romania, Finland, France, Italy, Denmark, Poland +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

Prevention of RSV infection in infants by administering nirsevimab to infants, with or without maternal RSV vaccination: a randomised controlled trial in France as part of the Pregnancy and Infant PrEparedness pLatform IN Europe (PIPELINE)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prevention Of Rsv trials by city

Prevention Of Rsv in Toronto Prevention Of Rsv in Vancouver Prevention Of Rsv in Montreal Prevention Of Rsv in Calgary Prevention Of Rsv in Edmonton Prevention Of Rsv in Ottawa Prevention Of Rsv in Winnipeg Prevention Of Rsv in Quebec City Prevention Of Rsv in Hamilton Prevention Of Rsv in Kitchener Prevention Of Rsv in London Prevention Of Rsv in Halifax Prevention Of Rsv in New York Prevention Of Rsv in Los Angeles Prevention Of Rsv in Chicago Prevention Of Rsv in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease